Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Gastroenterology. 2011 Apr 28;141(2):544–552. doi: 10.1053/j.gastro.2011.04.044

Figure 5.

Figure 5

PSD-95 expression pattern in rCCs at P60 following esophageal acid exposure at different time points of development. The treatment strategies were the same as indicated in fig. 1A. A: blots show PSD-95 and β-actin expression in individual animals (n=6/group) for 4 different groups. B: bar graphs represent relative intensity of staining against β-actin. *p<0.05 vs group 1, **p<0.001 vs group1, #p<0.05 vs group 2, € p<0.05 vs group 3.